Fatal Toxicities Vary by Immune Checkpoint Inhibitor Type
Oct 15, 2018
A study in JAMA Oncology found that a wide range of fatal toxic events can occur with immune checkpoint inhibitors, and the type of event varies by agent.
Recent Content
New Breakthrough Therapy Designated for Thyroid Cancer and NSCLC
Oct 15, 2018
LOXO-292, which selectively targets RET and has demonstrated preclinical activity against activating RET fusions/mutations, holds promise.
Thalidomide-Based Treatment Too Risky in Multiple Myeloma?
Oct 15, 2018
A study shows thalidomide-based treatment carries risk, but could be an option for certain multiple myeloma patients.
Quiz: Understand the Genetics of Skin Cancer
Oct 15, 2018
What role do genetics play in skin cancer? Test your knowledge with our latest quiz, while learning more about gene mutations.
Radiolabeled Peptide Offers Surgical Method for Assessing NETs
Oct 15, 2018
Radioguided surgery using gallium 68 dota peptides offers a highly sensitive method for detecting neuroendocrine tumors.
FDA Approves Once-Weekly Carfilzomib for Myeloma
Oct 15, 2018
FDA approves once-weekly carfilzomib/dexamethasone combo for relapsed or refractory multiple myeloma.
How Do Patients and Institutions Talk About Breast Cancer on Twitter?
Oct 12, 2018
In a first-of-its-kind study, researchers analyzed how Twitter users talk about breast cancer on the social media platform.
ZEB2 Biomarker May Improve TNM Risk-Stratification in CRC
Oct 11, 2018
A study shows ZEB2 has clinical potential and may improve TNM risk-stratification and guide treatment in colorectal cancer.
Does Diet Matter for Breast Cancer Survivors?
Oct 11, 2018
We take a look at how a healthy diet can improve quality of life in breast cancer survivors.
Improving Colorectal Cancer Screening For the Underserved
Oct 11, 2018
A study of an equal-access military health system shows universal health insurance for both the military and civilian populations could improve CRC screening rates.
